UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): April 1, 2026

Date of Report (date of earliest event reported): February 24, 2026

Merit Medical Systems, Inc.

(Exact name of registrant as specified in its charter)


Utah	0-18592	87-0447695
(State or other jurisdiction of	(Commission	(I.R.S. Employer
incorporation or organization)	File Number)	Identification No.)


1600 West Merit Parkway
South Jordan, Utah		84095
(Address of principal executive offices)		(Zip Code)

(801) 253-1600

(Registrant's telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, no par value MMSI NASDAQ Global Select Market ~~System~~

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

~~Item 2.02. Results of Operations and Financial Condition.~~

On February 24, 2026, Merit Medical Systems, Inc. (“Merit”) issued a press release announcing its operating and financial results for the quarter and year ended December 31, 2025. A copy of the press release is furnished as Exhibit 99.1 to this report and incorporated herein by reference.

Item 7.01. Regulation FD Disclosure.

On ~~February~~April 241, 2026, Merit isMedical ~~conducting~~Systems, aInc. ~~conference~~(“Merit”) ~~call~~issued toa ~~discuss~~press ~~its~~release ~~operating~~(the ~~and~~“Press ~~financial~~Release”) ~~results~~announcing ~~for~~that ~~the~~it ~~quarter~~has ~~and~~acquired ~~year~~View ~~ended~~Point ~~December 31~~Medical, ~~2025~~Inc. A(“View ~~live~~Point”) ~~webcast~~in ~~and~~a ~~slide~~merger ~~presentation~~transaction ~~will~~through ~~also~~which beView ~~available~~Point ~~for~~became a wholly-owned subsidiary of Merit (the ~~conference~~“Acquisition”). ~~call~~As ona result of the Acquisition, Merit acquired View Point’s ~~website~~OneMark® Detection Imaging System, OneMark Tissue Markers and related assets. AThe ~~copy~~aggregate ofAcquisition consideration, including the ~~slide~~assumption ~~presentation~~of isView ~~furnished~~Point asliabilities, ~~Exhibit~~is 99approximately $140 million.2 Of that amount, $90 million was paid in cash at closing and a total of two deferred payments of $25 million are scheduled to ~~this~~be ~~report~~paid not later than the first and ~~incorporated~~second ~~herein~~anniversaries byof ~~reference~~the closing date, respectively.

~~The~~A ~~information~~copy ~~contained~~of inthe ~~Item~~Press ~~2.02~~Release ~~and~~is ~~Item~~included 7as Exhibit 99.011 ofto this Current Report on Form ~~8-K~~ ~~(including the exhibits attached hereto) is furnished pursuant to General Instruction B.2. of Form~~ 8-K and ~~shall~~is not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated byherein ~~reference in any filing made~~ by ~~Merit under the Securities Act of 1933, as amended, or the Exchange Act~~reference.

~~In addition to disclosing results that are determined in accordance with Generally Accepted Accounting Principles (“GAAP”),~~ Merit isreferences ~~disclosing~~ non-GAAP financial ~~information in both the press release announcing its operating and financial results and the conference call presentation. Reconciliations of certain of these non-GAAP financial~~ measures ~~to the comparable GAAP financial measures are included~~ in the ~~press~~Press ~~release and conference call presentation attached as Exhibit 99~~Release.1 ~~and~~A ~~99.2,~~quantitative ~~respectively, to this report. Merit does not provide guidance for GAAP reported financial measures (other than revenue) or a~~ reconciliation of ~~forward-looking~~such non-GAAP financial ~~measures~~information to ~~the most directly~~ comparable GAAP ~~reported~~ financial measures (other than revenue) because Merit is unable to predict with reasonable certainty the financial impact of items such as expenses related to acquisitions or other extraordinary transactions, non-cash expenses related to amortization or write-off of previously acquired tangible and intangible assets, certain severance expenses, performance-based stock compensation expenses, expenses resulting from non-ordinary course litigation or administrative proceedings and resulting settlements, governmental proceedings, and changes in governmental or industry regulations. These items are uncertain, depend on various factors, and could have a material impact on GAAP reported results for the guidance period. For the same reasons, Merit is unable to address the significance of the unavailable information, ~~which could be material to future results. Specifically, Merit~~ is not, available without unreasonable effort, able to reliably predict the impact of these items and Merit believes inclusion of a reconciliation of these forward-looking non-GAAP figures to their GAAP counterparts could be confusing to investors or cause undue reliance.

The information contained in this Item 7.01 of this Current Report and in the attached Exhibit 99.1 is furnished pursuant to General Instruction B.2. of Form 8-K and shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing made by Merit under the Securities Act of 1933, as amended (the “Securities Act”), or the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

The information included in or furnished with this Current Report contains forward-looking statements about Merit that involve substantial risks and uncertainties. Merit intends such statements, and all subsequent forward-looking statements attributable to Merit, to be expressly qualified in their entirety by these cautionary statements and covered by the safe harbor provisions for forward-looking statements contained in Section 21E of the Exchange Act and Section 27A of the Securities Act. In some cases, forward-looking statements can be identified by the use of terminology such as “anticipate,” “believe,” “continue,” “estimate,” “expect,” “forecast,” “intend,” “may,” “might,” “plan,” “potential,” “project,” “will,” “would,” “seek,” “should,” “could,” “can,” “predict,” “potential,” “continue,” “objective” or other forms of these words or similar words or expressions, or the negative thereof or other comparable terminology. However, not all forward-looking statements contain such identifying words. All statements included in or furnished with this Current Report, other than statements of historical fact, are forward-looking statements for purposes of the Exchange Act and the Securities Act, including any such statements that address Merit’s future operating performance or events or developments that Merit’s management expects or anticipates will occur, including, without limitation, any statements regarding Merit’s projected revenues, growth in revenue, earnings, earnings per share, non-GAAP earnings per share, gross margin, non-GAAP gross margin, operating margin, non-GAAP operating margin, or other financial measures, Merit’s plans and objectives for future operations, Merit’s proposed new products or services, the integration, development or commercialization of the business or any assets acquired from another party, including View Point, future economic conditions or performance, the implementation of, and results which may be achieved through, Merit’s Continued Growth Initiatives Program or other business optimization initiatives, and any statements of assumptions underlying any of the foregoing.

Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Merit’s actual results, levels of activity, performance or achievement to be materially different from those expressed or implied by these forward-looking statements, including those risks, uncertainties and other factors described in Merit’s Annual Report on Form 10-K for the year ended December 31, 2025 and subsequent filings with the SEC.

All forward-looking statements included in this Current Report or any document furnished herewith speak only as of the date made, are based on information available to Merit as of such date, and are subject to change. Merit assumes no obligation to update or revise any forward-looking statement. If Merit does update or correct one or more forward-looking statements, readers should not conclude that Merit will make additional updates or corrections. Merit’s actual results will likely differ, and may differ materially, from anticipated results. Readers should not unduly rely on any such forward-looking statements.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits


EXHIBIT NUMBER		DESCRIPTION

99.1		Press Release, dated ~~February~~April 241, 2026, entitled “Merit Medical ~~Reports~~Acquires ~~Fourth~~View ~~Quarter~~Point ~~and~~Medical, ~~Full~~Inc., ~~Year~~expanding ~~2025~~the ~~Results~~Merit ~~and~~Therapeutic ~~Issues~~Oncology ~~Fiscal Year 2026 Guidance~~Portfolio” ~~including unaudited financial information.~~
99.2		Conference Call Presentation
104		The cover page from this Current Report on Form 8-K, formatted in Inline XBRL

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


	MERIT MEDICAL SYSTEMS, INC.


Date: February 24, 2026	By:	/s/ Brian G. Lloyd
Date: April 1, 2026	By:	/s/ Brian G. Lloyd
		Brian G. Lloyd
		Chief Legal Officer and Corporate Secretary

Filing Compare · MERIT MEDICAL SYSTEMS INC